Recovery of IFN-γ levels in PBMCs from lepromatous leprosy patients through the synergistic actions of the cytokines IL-12 and IL-18

International Immunopharmacology

Volumn 8, Issue 13-14, 2008, Pages 1715-1720

  Lopez Roa, Rocio Ivette ^a   Guerrero Velásquez, Celia ^a   Alvarado Navarro, Anabell ^a   Montoya Buelna, Margarita ^a   Garcia Niebla, Cesar ^b   Fafutis Morris, Mary ^a  

^a INSTITUTO DERMATOLÓGICO DE JALISCO DR JOSÉ BARBA RUBIO   (Mexico)

^b Instituto Dermatologico de Sinaloa   (Mexico)

Author keywords

Cytokines; IL12 IL18; Intracellular infection; Leprosy; Mycobacterium leprae; Synergistic

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 18 RECEPTOR; RECOMBINANT INTERLEUKIN 12; RECOMBINANT INTERLEUKIN 18; TRANSCRIPTION FACTOR;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL CULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; DRUG POTENTIATION; HUMAN; LEPROMATOUS LEPROSY; MACROPHAGE; MYCOBACTERIUM LEPRAE; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL PROLIFERATION; CELLS, CULTURED; DRUG SYNERGISM; FEMALE; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-18 RECEPTOR ALPHA SUBUNIT; LEPROSY, LEPROMATOUS; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; MITOGENS; MYCOBACTERIUM LEPRAE; PHYTOHEMAGGLUTININS; RECOMBINANT PROTEINS;

EID: 55249101573     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2008.07.010     Document Type: Article

References (37)

1. Billiau A., Heremans H., Vermeire K., and Matthys P. Immunomodulatory properties of interferon-gamma. An update. Ann N Y Acad Sci 856 (Sep 29 1998) 22-32
2. Tau G., and Rothman P. Biologic functions of the IFN-gamma receptors. Allergy 54 12 (Dec 1999) 1233-1251
3. van de Vosse E., Hoeve M.A., and Ottenhoff T.H. Human genetics of intracellular infectious diseases: molecular and cellular immunity against mycobacteria and salmonellae. Lancet Infect Dis 4 12 (Dec 2004) 739-749
4. Nakahira M., Ahn H.J., Park W.R., Gao P., Tomura M., Park C.S., et al. Synergy of IL-12 and IL-18 for IFN-gamma gene expression: IL-12-induced STAT4 contributes to IFN-gamma promoter activation by up-regulating the binding activity of IL-18-induced activator protein 1. J Immunol 168 3 (Feb 1 2002) 1146-1153
5. Nembrini C., Abel B., Kopf M., and Marsland B.J. Strong TCR signaling, TLR ligands, and cytokine redundancies ensure robust development of type 1 effector T cells. J Immunol 176 12 (Jun 15 2006) 7180-7188
6. Yoshimoto T., Takeda K., Tanaka T., Ohkusu K., Kashiwamura S., Okamura H., et al. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: synergism with IL-18 for IFN-gamma production. J Immunol 161 7 (Oct 1 1998) 3400-3407
7. Maxwell J.R., Yadav R., Rossi R.J., Ruby C.E., Weinberg A.D., Aguila H.L., et al. IL-18 bridges innate and adaptive immunity through IFN-gamma and the CD134 pathway. J Immunol 177 1 (Jul 1 2006) 234-245
8. Akira S. The role of IL-18 in innate immunity. Curr Opin Immunol 12 1 (Feb 2000) 59-63
9. Schindler H., Lutz M.B., Rollinghoff M., and Bogdan C. The production of IFN-gamma by IL-12/IL-18-activated macrophages requires STAT4 signaling and is inhibited by IL-4. J Immunol 166 5 (Mar 1 2001) 3075-3082
10. Barbulescu K., Becker C., Schlaak J.F., Schmitt E., Meyer zum Buschenfelde K.H., and Neurath M.F. IL-12 and IL-18 differentially regulate the transcriptional activity of the human IFN-gamma promoter in primary CD4+ T lymphocytes. J Immunol 160 8 (Apr 15 1998) 3642-3647
11. Lawless V.A., Zhang S., Ozes O.N., Bruns H.A., Oldham I., Hoey T., et al. Stat4 regulates multiple components of IFN-gamma-inducing signaling pathways. J Immunol 165 12 (Dec 15 2000) 6803-6808
12. Abulafia J., and Vignale R.A. Leprosy: pathogenesis updated. Int J Dermatol 38 5 (May 1999) 321-334
13. Abulafia J., and Vignale R.A. Leprosy: accessory immune system as effector of infectious, metabolic, and immunologic reactions. Int J Dermatol 40 11 (Nov 2001) 673-687
14. Libraty D.H., Airan L.E., Uyemura K., Jullien D., Spellberg B., Rea T.H., et al. Interferon-gamma differentially regulates interleukin-12 and interleukin-10 production in leprosy. J Clin Invest 99 2 (Jan 15 1997) 336-341
15. Ridley D.S., and Jopling W.H. Classification of leprosy according to immunity. A five-group system. Int J Lepr Other Mycobact Dis 34 3 (Jul-Sep 1966) 255-273
16. Chemotherapy of leprosy for control programmes. W H O Tech Rep Ser 675 (1982) 1-33
17. Boyum A. Separation of leukocytes from blood and bone marrow. Introduction. Scand J Clin Lab Invest Suppl 97 (1968) 7
18. Mohagheghpour N., Gelber R.R., and Engleman E.G. T cell defect in lepromatous leprosy is reversible in vitro in the absence of exogenous growth factors. J Immunol 138 2 (Jan 15 1987) 570-574
19. Rees R.J. A century of progress in experimental leprosy. Int J Lepr Other Mycobact Dis 41 3 (Jul-Sep 1973) 320-328
20. Colston M.J., and Hilson G.R. Growth of Mycobacterium leprae and M. marinum in congenitally athymic (nude) mice. Nature 262 5567 (Jul 29 1976) 399-401
21. Scollard D.M., Adams L.B., Gillis T.P., Krahenbuhl J.L., Truman R.W., and Williams D.L. The continuing challenges of leprosy. Clin Microbiol Rev 19 2 (Apr 2006) 338-381
22. Fafutis-Morris M., Alfaro-Bustamante F., Gonzalez-Mendoza A., Morales-Ortiz R., and Islas-Rodriguez A.E. Response to phytohemagglutinin of LL patients' lymphocytes preincubated in culture media. Int J Lepr Other Mycobact Dis 59 3 (Sep 1991) 480-482
23. Islas-Rodriguez A.E., Morales-Ortiz R., Fafutis-Morris M., Gonzalez-Mendoza A., and Ortiz-Ortiz L. Deficiency in the biosynthesis of interleukin 2 (IL-2) and functional presence of the IL-2 receptor in lepromatous leprosy. Int J Lepr Other Mycobact Dis 55 3 (Sep 1987) 566-569
24. Sieling P.A., and Modlin R.L. Cytokine patterns at the site of mycobacterial infection. Immunobiology 191 4-5 (Oct 1994) 378-387
25. Ottenhoff T.H., Verreck F.A., Lichtenauer-Kaligis E.G., Hoeve M.A., Sanal O., and van Dissel J.T. Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae. Nat Genet 32 1 (Sep 2002) 97-105
26. Aderem A. Role of toll-like receptors in inflammatory response in macrophages. Crit Care Med 29 7 Suppl (Jul 2001) S16-18
27. Krutzik S.R., Ochoa M.T., Sieling P.A., Uematsu S., Ng Y.W., Legaspi A., et al. Activation and regulation of Toll-like receptors 2 and 1 in human leprosy. Nat Med 9 5 (May 2003) 525-532
28. Garcia V.E., Uyemura K., Sieling P.A., Ochoa M.T., Morita C.T., Okamura H., et al. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection. J Immunol 162 10 (May 15 1999) 6114-6121
29. Kim J., Uyemura K., Van Dyke M.K., Legaspi A.J., Rea T.H., Shuai K., et al. A role for IL-12 receptor expression and signal transduction in host defense in leprosy. J Immunol 167 2 (Jul 15 2001) 779-786
30. Yamamura M., Wang X.H., Ohmen J.D., Uyemura K., Rea T.H., Bloom B.R., et al. Cytokine patterns of immunologically mediated tissue damage. J Immunol 149 4 (Aug 15 1992) 1470-1475
31. Little D., Khanolkar-Young S., Coulthart A., Suneetha S., and Lockwood D.N. Immunohistochemical analysis of cellular infiltrate and gamma interferon, interleukin-12, and inducible nitric oxide synthase expression in leprosy type 1 (reversal) reactions before and during prednisolone treatment. Infect Immun 69 5 (May 2001) 3413-3417
32. Mosmann T.R., Cherwinski H., Bond M.W., Giedlin M.A., and Coffman R.L. Two types of murine helper T cell clone. I Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136 7 (Apr 1 1986) 2348-2357
33. Lockhart E., Green A.M., and Flynn J.L. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J Immunol 177 7 (Oct 1 2006) 4662-4669
34. Umemura M., Yahagi A., Hamada S., Begum M.D., Watanabe H., Kawakami K., et al. IL-17-mediated regulation of innate and acquired immune response against pulmonary Mycobacterium bovis bacille Calmette-Guerin infection. J Immunol 178 6 (Mar 15 2007) 3786-3796
35. Cruz A., Khader S.A., Torrado E., Fraga A., Pearl J.E., Pedrosa J., et al. Cutting edge: IFN-gamma regulates the induction and expansion of IL-17-producing CD4 T cells during mycobacterial infection. J Immunol 177 3 (Aug 1 2006) 1416-1420
36. McGill P.E. Geographically specific infections and arthritis, including rheumatic syndromes associated with certain fungi and parasites, Brucella species and Mycobacterium leprae. Best Pract Res Clin Rheumatol 17 2 (Apr 2003) 289-307
37. Khader S.A., Pearl J.E., Sakamoto K., Gilmartin L., Bell G.K., Jelley-Gibbs D.M., et al. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available. J Immunol 175 2 (Jul 15 2005) 788-795